Teresa Núñez de Villavicencio-Díaz

Teresa Núñez de Villavicencio-Díaz

Auto-generated profile, based on publicly available information

Teresa Núñez de Villavicencio-Díaz

Department of Systems Biology, Center for Genetic Engineering and Biotechnology, Cuba

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2017 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TVTeresa Nuñez de Villavicencio-Diaz
Teresa Nuñez de Villavicencio-Diaz
ARAdam J. Rabalski
Adam J. Rabalski
DLDavid Litchfield
David Litchfield
Protein kinase CK2 is a small family of protein kinases that has been implicated in an expanding array of biological processes. While it is widely accepted that CK2 is a regulatory participant in a multitude of fundamental cellular processes, CK2 is often considered to be a constitutively active enzyme which raises questions about how it can be a regulatory participant in intricately controlled cellular processes. To resolve this apparent paradox, we have performed a systematic analysis of the published literature using text mining as well as mining of proteomic databases together with computational assembly of networks that involve CK2. These analyses reinforce the notion that CK2 is involved in a broad variety of biological processes and also reveal an extensive interplay between CK2 phosphorylation and other post-translational modifications. The interplay between CK2 and other post-translational modifications suggests that CK2 does have intricate roles in orchestrating cellular events. In this respect, phosphorylation of specific substrates by CK2 could be regulated by other post-translational modifications and CK2 could also have roles in modulating other post-translational modifications. Collectively, these observations suggest that the actions of CK2 are precisely coordinated with other constituents of regulatory cellular networks.

10 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
TBThierry Le Bihan
Thierry Le Bihan
TDTeresa Nunez de Villavicencio Diaz
Teresa Nunez de Villavicencio Diaz
CRChelsea Reitzel
Chelsea Reitzel
VLVictoria Lange
Victoria Lange
MPMinyoung Park
Minyoung Park
BMBin Ma
Bin Ma
The antibody response to vaccination and infection is a key component of the immune response to pathogens. Sequencing of peripheral B cells may not represent the complete B cell receptor repertoire. Here we present a method for sequencing human plasma-derived polyclonal IgG using a combination of mass spectrometry and B-cell sequencing. We investigate the IgG response to the Moderna Spikevax COVID-19 vaccine. From the sequencing data of the natural polyclonal response to vaccination, we generate 12 recombinant antibodies. Six derived recombinant antibodies, including four generated with de novo protein sequencing, exhibit similar or higher binding affinities than the original natural polyclonal antibody. Neutralization tests reveal that the six antibodies possess neutralizing capabilities against the target antigen. This research provides insights into sequencing polyclonal IgG antibodies and the potential of our approach in generating recombinant antibodies with robust binding affinity and neutralization capabilities. Directly examining the circulating IgG pool is crucial due to potential misrepresentations by B-cell analysis alone.

1 August 2015 in Journal of Proteomics
Verified
Journal Article
Closed access
TVTeresa Núñez de Villavicencio-Díaz
Teresa Núñez de Villavicencio-Díaz
YGYassel Ramos Gómez
Yassel Ramos Gómez
BABrizaida Oliva Argüelles
Brizaida Oliva Argüelles
JMJulio Raúl Fernández Massó
Julio Raúl Fernández Massó
ARArielis Rodríguez-Ulloa
Arielis Rodríguez-Ulloa
MVMaribel Guerra Vallespi
Maribel Guerra Vallespi

31 January 2014 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
TVTeresa Nunez Villavicencio-Diaz
Teresa Nunez Villavicencio-Diaz
ARArielis Rodriguez-Ulloa
Arielis Rodriguez-Ulloa
Osmany GuirolaOsmany Guirola
Osmany Guirola
YPYasset Perez-Riverol
Yasset Perez-Riverol
Proteins are the principal mediators of the functions in the cell; therefore, any abnormal variations on their abundance levels may reflect the presence of pathological processes. In this sense, many researchers rely on the functional interpretation of protein lists generated by quantitative proteomics experiments to analyze, for instance, these variations in the context of diseases´ molecular basis and drug discovery. Since no analytical strategy or bioinformatics tool by itself is capable of extract all the information covered by a single experiment; herein we seek to provide the biologists with four groups of different but complementary bioinformatics tools for the functional interpretation of quantitative proteomics results. To this end we will review the basic concepts of a set of different bioinformatics approaches and we will give examples of freely available tools for each one of these approaches.

20 August 2015 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
TVTeresa Núñez de Villavicencio-Díaz
Teresa Núñez de Villavicencio-Díaz
YMYuliet Mazola
Yuliet Mazola
YNYasser Perera Negrin
Yasser Perera Negrin
YGYiliam Cruz García
Yiliam Cruz García
Osmany GuirolaOsmany Guirola
Osmany Guirola
SRSilvio E. Perea Rodríguez
Silvio E. Perea Rodríguez
CK2 is a constitutively active Ser/Thr protein kinase deregulated in cancer and other pathologies, responsible for about the 20% of the human phosphoproteome. The holoenzyme is a complex composed of two catalytic (α or α´) and two regulatory (β) subunits, with individual subunits also coexisting in the cell. In the holoenzyme, CK2β is a substrate-dependent modulator of kinase activity. Therefore, a comprehensive characterization of CK2 cellular function should firstly address which substrates are phosphorylated exclusively when CK2β is present (class-III or beta-dependent substrates). However, current experimental constrains limit this classification to a few substrates. Here, we took advantage of motif-based prediction and designed four linear patterns for predicting class-III behavior in sets of experimentally determined CK2 substrates. Integrating high-throughput substrate prediction, functional classification and network analysis, our results suggest that beta-dependent phosphorylation might exert particular regulatory roles in viral infection and biological processes/pathways like apoptosis, DNA repair and RNA metabolism. It also pointed, that human beta-dependent substrates are mainly nuclear, a few of them shuttling between nuclear and cytoplasmic compartments.

20 August 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LTLouise Turner
Louise Turner
TDTeresa Nunez de Villavicencio Diaz
Teresa Nunez de Villavicencio Diaz
SRSai Sundar Rajan Raghavan
Sai Sundar Rajan Raghavan
IKIkhlaq Hussain Kana
Ikhlaq Hussain Kana
ELEric Lyimo
Eric Lyimo
TLThomas Lavstsen
Thomas Lavstsen
Plasmodium falciparum pathology is driven by the accumulation of parasite-infected erythrocytes in blood capillaries. This sequestration process is mediated by the parasite’s P. falciparum erythrocyte membrane protein 1 (PfEMP1) adhesins, which bind select endothelial cell receptors. A subset of PfEMP1 binding human endothelial protein C receptor (EPCR) through their cysteine-rich interdomain region alpha 1 (CIDRα1) domains drives the pathogenesis to severe malaria. Despite high sequence diversity among CIDRα1 domains, individuals living in malaria-endemic regions become immune to severe disease in part through acquisition of antibodies inhibiting the PfEMP1–EPCR interaction. Here, we demonstrate an approach to identify pathogen-specific human monoclonal antibodies from plasma, combining mass spectrometry analysis of antigen-purified polyclonal plasma IgG and Ig transcript sequencing. We identified a clonal family of broadly reactive and EPCR binding-inhibitory human monoclonal antibodies against CIDRα1. The antibodies, isolated from a 9-y-old child, exhibited potent inhibition of EPCR binding broadly across CIDRα1 domains as well as binding of infected erythrocytes to EPCR. Structural analysis of one antibody variant complexed with CIDRα1 revealed a shared epitope of the clonal antibody family overlapping the EPCR binding site and the epitopes of two previously identified monoclonal antibodies, C7 and C74, with similar functional patterns. However, although C7, C74, and 110-3 antibodies all depend on the same few residues conserved in CIDRα1 to retain EPCR binding, the 110-3 antibodies contact additional variable residues, reducing their breadth of reactivity across the CIDRα1 family. These data bolster the hypothesis that broadly inhibitory antibodies against severe malaria-associated PfEMP1 target similar epitopes and are commonly developed in malaria-exposed individuals.